Merck & Co.报告Q4收入强劲,超过了预期,提高了红利。 Merck & Co. reported strong Q4 earnings, exceeding expectations and raising its dividend.

Merck & Co.报告Q4收入强劲,超过分析师的预期,EPS为15.7美元,收入为166.6亿美元。 Merck & Co. reported strong Q4 earnings, exceeding analyst expectations with a $1.57 EPS and $16.66 billion in revenue. 由于机构投资者对其持有的股份作了各种调整,公司股票略有上升。 The company's stock rose slightly as institutional investors made various adjustments to their holdings. Merck将其红利增加到每股0.81美元,收益率为3.21%。 Merck increased its dividend to $0.81 per share, giving a 3.21% yield. 分析师给予Merck“机动购买”评级,目标价格为123.67美元。 Analysts have given Merck a "Moderate Buy" rating with a target price of $123.67. 该公司在制药、动物健康和其他部门开展业务,提供一系列保健解决方案。 The company operates in pharmaceuticals, animal health, and other segments, providing a range of health solutions.